Results 171 to 180 of about 46,872 (243)

Demonstration of autonomous fixed‐wing drone delivery of prescribed medications in remote islands in Japan

open access: yesJournal of General and Family Medicine, Volume 26, Issue 3, Page 195-204, May 2025.
We demonstrated a combination of online medication counseling and drone delivery of medications dispensed by pharmacists in two rural clinics located far from pharmacies on remote islands in Japan. After being prescribed by physicians, dispensed by pharmacists, and online medication counseling, the medications were transported by autonomous fixed‐wing ...
Jun Miyata   +5 more
wiley   +1 more source

Unveiling Prescribing Patterns: A Systematic Review of Chronic Opioid Prescriptions After Head and Neck Cancer Surgeries

open access: yesOtolaryngology–Head and Neck Surgery, Volume 172, Issue 5, Page 1512-1520, May 2025.
Abstract Objective This study aims to review opioid prescribing changes for pain management in head and neck cancer (HNC) surgery patients, given the recent focus on Enhanced Recovery After Surgery protocols. Data Sources MEDLINE, Embase, and CENTRAL, covering 1998 to 2023.
Sabin Karki   +9 more
wiley   +1 more source

Toward Personalized Immunotherapeutic Drug Monitoring with Multiplexed Extended‐Gate Field‐Effect‐Transistor Biosensors

open access: yesSmall Science, Volume 5, Issue 5, May 2025.
In this study, a proof of concept is presented using an extended‐gate field‐effect‐transistor biosensing platform for monitoring immunotherapeutic drugs in vivo. Using varying sizes of immunotherapeutic drugs, the biosensor surpasses the sensitivity of standard methods, reducing the need for radioactive labeling in real‐time sensing.
Trang‐Anh Nguyen‐Le   +8 more
wiley   +1 more source

Nationwide trends in diagnosed sedative, hypnotic or anxiolytic use disorders in adolescents and young adults enrolled in Medicaid: 2001–2019

open access: yesAddiction, Volume 120, Issue 5, Page 951-961, May 2025.
Abstract Background and Aim Sedative, hypnotic or anxiolytic use disorders (SHA‐UD) are defined by significant impairment or distress caused by recurrent sedative, hypnotic or anxiolytic use. This study aimed to measure trends in the prevalence of SHA‐UD diagnoses in adolescent and young adult US Medicaid enrollees from 2001 to 2019.
Greta Bushnell   +6 more
wiley   +1 more source

Home - About - Disclaimer - Privacy